New test may detect Alzheimer’s disease earlier

Date:

Share this article:

Del denne artikel:

Alzheimer’s is often diagnosed late in the course of the disease, which is why researchers have been investigating whether a simpler test could provide answers at an earlier stage.

Alzheimer’s disease is difficult to detect in its early phases. Today, diagnosis is often based on brain scans, samples of cerebrospinal fluid, and cognitive tests.

According to researchers, these methods can be both burdensome and expensive and are therefore typically used only once symptoms are already affecting daily life.

As a result, research is focusing on new ways to identify the disease earlier, preferably using less invasive methods.

Focus on energy in the brain

According to a research update from Northern Arizona University, a research team is studying how the brain uses glucose, its primary source of energy.

Also read: This is what happens to your immune system when you eat kimchi

The project is led by Travis Gibbons from the Department of Biological Sciences and is supported, among others, by the Arizona Alzheimer’s Association.

Travis Gibbons explains to Science Daily that the brain’s energy consumption declines in people with Alzheimer’s disease.

A healthy brain normally uses a large amount of energy, he explains.

An early decline in this process may therefore serve as a warning sign before symptoms become obvious.

Also read: 47-year-old man died after eating a burger

Blood tests instead of invasive procedures

Previously, invasive methods were required to measure the brain’s metabolism.

According to Northern Arizona University, researchers are now examining an alternative approach based on microvesicles in the blood.

These small particles can originate from nerve cells and contain information about the condition of the brain.

Travis Gibbons describes the method as less invasive, although it is still under development and requires extensive laboratory work.

Also read: Scientists may have found a protein that helps living longer – at least in mice

Opportunities and limitations

The study is initially being tested on healthy individuals and later on people with mild cognitive impairment and Alzheimer’s disease.

This means that the results cannot yet be used in the healthcare system.

However, Travis Gibbons sees long-term potential and says there may soon be an opportunity to help people with early-stage Alzheimer’s.

According to the university, this could ultimately reduce the burden on both patients and society.

Also read: Scientists find new way to assess heart disease risk

Sources: Science Daily, and Northern Arizona University.

Also read: How to distinguish between Covid-19 and influenza

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Feeling physically weaker or slower than before? Your heart may be sending a warning years early

A new look at thousands of older adults suggests the slowdown we blame on aging may mean something more.

More than half of young adults put their type 2 diabetes into remission without drugs

The plan behind it was tough, tightly supervised, and worked on patients clinicians often struggle to reach.

An AI learned to see a migraine coming the next day, from a signal clinicians often overlook

Built on nearly 800,000 diary days from people living with migraine, the forecast was far more accurate than many had expected.

The same workout may affect men’s and women’s livers differently

Researchers watched the same workout play out inside the body in two very different ways, depending on sex.

Feeling physically weaker or slower than before? Your heart may be sending a warning years early

A new look at thousands of older adults suggests the slowdown we blame on aging may mean something more.

More than half of young adults put their type 2 diabetes into remission without drugs

The plan behind it was tough, tightly supervised, and worked on patients clinicians often struggle to reach.

An AI learned to see a migraine coming the next day, from a signal clinicians often overlook

Built on nearly 800,000 diary days from people living with migraine, the forecast was far more accurate than many had expected.